MedTrace Logo

Nutraceutical on Hyperglycemia

NCT04107922 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2019-10-01

No results posted yet for this study

Summary

The aim will be to evaluate if Glicoset® 1000, a nutraceutical containing Ilex Paraguariensis, White Mulberry and Chromium Picolinate, can be effective in improving glycemic status in subject with dysglycemia.

Conditions

  • Dysglycemia

Interventions

DIETARY_SUPPLEMENT

Glicoset

Patients will take a nutraceutical containing Ilex Paraguariensis, White Mulberry and Chromium Picolinate

OTHER

Placebo

Patients will take placebo

Sponsors & Collaborators

  • University of Pavia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2019-08-31
Completion
2019-08-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04107922 on ClinicalTrials.gov